標(biāo)題: Titlebook: Handbook of Diabetes Technology; Yves Reznik Book 2019 Springer Nature Switzerland AG 2019 Continuous glucose monitoring.Implantable insul [打印本頁(yè)] 作者: intern 時(shí)間: 2025-3-21 16:09
書目名稱Handbook of Diabetes Technology影響因子(影響力)
書目名稱Handbook of Diabetes Technology影響因子(影響力)學(xué)科排名
書目名稱Handbook of Diabetes Technology網(wǎng)絡(luò)公開度
書目名稱Handbook of Diabetes Technology網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Handbook of Diabetes Technology被引頻次
書目名稱Handbook of Diabetes Technology被引頻次學(xué)科排名
書目名稱Handbook of Diabetes Technology年度引用
書目名稱Handbook of Diabetes Technology年度引用學(xué)科排名
書目名稱Handbook of Diabetes Technology讀者反饋
書目名稱Handbook of Diabetes Technology讀者反饋學(xué)科排名
作者: 啤酒 時(shí)間: 2025-3-21 21:36 作者: 痛苦一生 時(shí)間: 2025-3-22 03:49 作者: Chronological 時(shí)間: 2025-3-22 04:39 作者: 招募 時(shí)間: 2025-3-22 10:44
Anlass, Ziele und theoretische Rahmung,f diabetes. This first era of diabetes research ran from the 1920s to the 1970s and can be summarized as the “childhood years” where most of the pathophysiological and therapeutic basic concepts were described and established.作者: Foment 時(shí)間: 2025-3-22 13:00 作者: extract 時(shí)間: 2025-3-22 19:32 作者: jaundiced 時(shí)間: 2025-3-22 21:48 作者: 新鮮 時(shí)間: 2025-3-23 05:02 作者: 后天習(xí)得 時(shí)間: 2025-3-23 09:01 作者: CEDE 時(shí)間: 2025-3-23 11:56
ugh applied technologies. ..The different chapters include insulin therapy through basic insulin injection therapy, external and implantable insulin pumps and the more recent approaches such as sensor augmented pumps and close-loop systems. Islet transplantation is also described through its technic作者: neutralize 時(shí)間: 2025-3-23 15:17
Book 2019insulin injection therapy, external and implantable insulin pumps and the more recent approaches such as sensor augmented pumps and close-loop systems. Islet transplantation is also described through its technical aspects and clinical evaluation. Glucose measurement through blood glucose meters and 作者: 灌溉 時(shí)間: 2025-3-23 19:24 作者: hegemony 時(shí)間: 2025-3-23 23:43
help professionals involved in diabetes management understanding the contribution of diabetes technologies for promoting the optimization of? glucose control and monitoring. This volume will be helpful in current clinical practice for diabetes management and also beneficial to students..978-3-319-98119-2作者: 鞏固 時(shí)間: 2025-3-24 05:19
Unternehmenskultur – Worüber reden wir?bration as it is “factory calibrated” (see below). Life span of each sensor type is linked to the subcutaneous stability of GOx and its ability to catalyze glucose oxidation over time. Non-electrochemical technologies are also developed for CGM but are not currently available in routine practice (op作者: 護(hù)航艦 時(shí)間: 2025-3-24 08:37 作者: 懲罰 時(shí)間: 2025-3-24 11:48 作者: 裂縫 時(shí)間: 2025-3-24 17:41 作者: Iatrogenic 時(shí)間: 2025-3-24 20:39
Continuous Glucose Monitoring Systems,bration as it is “factory calibrated” (see below). Life span of each sensor type is linked to the subcutaneous stability of GOx and its ability to catalyze glucose oxidation over time. Non-electrochemical technologies are also developed for CGM but are not currently available in routine practice (op作者: 抓住他投降 時(shí)間: 2025-3-25 00:20
Closed-Loop Systems,rogress by more accurate sensors for glucose monitoring, wearable platforms for running algorithms and wireless communication between devices. The approval by the FDA of a first closed-loop insulin delivery system for routine therapy of type 1 diabetes in September 2016 illustrates the maturity reac作者: Hemiplegia 時(shí)間: 2025-3-25 05:07 作者: 離開可分裂 時(shí)間: 2025-3-25 09:35 作者: Thyroxine 時(shí)間: 2025-3-25 15:19
Introduction to Diabetes Technologies,initiating the first therapeutic use of an extracted natural hormone, and this breakthrough was later followed by the first radioimmunological assay for the measurement of a circulating hormone (1960) and then by the first recombinant hormone ever produced (1978). These achievements led to several N作者: 排出 時(shí)間: 2025-3-25 17:35
Subcutaneous Insulin Pumps,ntinuous subcutaneous insulin infusion (CSII) delivery pattern insures a reduction of hyperglycemic events and HbA1c after the switch from multiple daily injections in patients with type 1 and type 2 diabetes. Moreover, the coupling of continuous glucose monitoring to pump therapy, named sensor augm作者: 灌輸 時(shí)間: 2025-3-25 23:32 作者: 動(dòng)機(jī) 時(shí)間: 2025-3-26 01:48
The Implantable Insulin Pump,ir diabetes despite all appropriate medical and educational efforts. The implanted pump provides an added efficacy for glycemic variability, hypoglycemia, and HbA1c as compared to the external pump’s subcutaneous insulin delivery. This is due to the intraperitoneal insulin administration which is no作者: 水汽 時(shí)間: 2025-3-26 05:53
Closed-Loop Systems,ulin. They include a continuous glucose monitoring device, a control algorithm and an insulin infusion pump. The control algorithm is the key of the system since it commands insulin infusion in order to maintain blood glucose in a predefined target range or close to a target glucose level. Algorithm作者: forecast 時(shí)間: 2025-3-26 10:37
Islet Transplantation,o date, no preventive or curative treatment for type 1 diabetes mellitus has been successfully translated to standard clinical care. Type 1 diabetes treatment is based on lifelong multi-daily injections of exogenous insulin. In the last decades, considerable improvements in diabetes management have 作者: Hyperlipidemia 時(shí)間: 2025-3-26 16:17
Software in Diabetes, affected in 2015, an increase to 642 million is projected to occur by 2040 [1]. Five million adults died from diabetes in 2015. Diabetes is a major cause of premature death, individual disability, and reduced quality of life. The estimated total cost of diabetes care is rising every year worldwide 作者: glacial 時(shí)間: 2025-3-26 17:34
Telemedicine and Diabetes,y in terms of volume of publications regarding telemedicine in Medline [1]. While the value of telemedicine has already been demonstrated in screening for diabetic retinopathy and/or follow-up of diabetic foot lesions, most of the studies in telemedicine with regard to diabetology continue to focus 作者: 無能的人 時(shí)間: 2025-3-26 21:21 作者: triptans 時(shí)間: 2025-3-27 05:00
Anlass, Ziele und theoretische Rahmung,initiating the first therapeutic use of an extracted natural hormone, and this breakthrough was later followed by the first radioimmunological assay for the measurement of a circulating hormone (1960) and then by the first recombinant hormone ever produced (1978). These achievements led to several N作者: 馬具 時(shí)間: 2025-3-27 06:48 作者: Palate 時(shí)間: 2025-3-27 12:31
Unternehmenskultur – Worüber reden wir?easures interstitial glucose levels; (2) a transmitter connected (physically or wireless) to the sensor; and (3) a receiver displaying glucose data. The technology of these sensors relies on an electrochemical approach using glucose oxidase enzyme (GOx). Sensors are coated with GOx that catalyzes th作者: 上下連貫 時(shí)間: 2025-3-27 16:19 作者: FADE 時(shí)間: 2025-3-27 21:16 作者: 哄騙 時(shí)間: 2025-3-27 21:55 作者: 收藏品 時(shí)間: 2025-3-28 05:18
Vorbereitung des Kulturwandels, affected in 2015, an increase to 642 million is projected to occur by 2040 [1]. Five million adults died from diabetes in 2015. Diabetes is a major cause of premature death, individual disability, and reduced quality of life. The estimated total cost of diabetes care is rising every year worldwide 作者: Psa617 時(shí)間: 2025-3-28 09:29
Unternehmenskultur und Strategiey in terms of volume of publications regarding telemedicine in Medline [1]. While the value of telemedicine has already been demonstrated in screening for diabetic retinopathy and/or follow-up of diabetic foot lesions, most of the studies in telemedicine with regard to diabetology continue to focus 作者: ALLAY 時(shí)間: 2025-3-28 14:13 作者: 笨拙的你 時(shí)間: 2025-3-28 16:36 作者: 自作多情 時(shí)間: 2025-3-28 20:08
http://image.papertrans.cn/h/image/421150.jpg作者: NOMAD 時(shí)間: 2025-3-29 02:38
Springer Nature Switzerland AG 2019
